All articles tagged with #pharmaceutical pricing
The U.S. and the UK have reached an agreement in principle to address pharmaceutical trade imbalances, including the UK increasing payments for new medicines and the U.S. exempting UK pharmaceuticals from tariffs, aiming to lower drug costs for Americans and boost pharmaceutical innovation and investment.
Gilead Sciences' new HIV prevention shot, Yeztugo, shows high efficacy but faces challenges in adoption due to its high $28,000 price tag, with CVS Caremark declining to include it in its formulary despite other insurers moving forward, raising concerns about affordability and disease eradication efforts in the U.S.
The US is planning to reduce the prices of obesity drugs that are offered on a website associated with Trump, aiming to make these medications more affordable.
President Trump announced a deal with Eli Lilly and Novo Nordisk to significantly reduce the prices of popular weight loss drugs for eligible Medicare and Medicaid patients, with plans to launch the TrumpRx program offering these medications at lower costs starting in January, aiming to improve health outcomes and reduce obesity-related risks.
Novo Nordisk has halved the US price of Ozempic, a popular diabetes medication, as part of its efforts to improve accessibility and address concerns over drug pricing.